PharmMD Expands Advisory Board
New members of the PharmMD advisory board include Martin Makary, M.D.;Michael Burcham; and Kevin Hutchinson. The three join an elite group ofadvisors that has helped PharmMD launch and hone its MTM services, which workto guard against medication error, misuse, overuse and abuse. MTM is provento reduce the cost of providing drug benefits and improve the health ofindividual patients by taking measures to ensure they receive the mostappropriate medications.
Martin Makary, M.D., is an active surgeon at The Johns Hopkins Hospitaland professor for the university's Bloomberg School of Public Health. Dr.Makary currently serves in leadership roles for the United Nations WorldHealth Organization (WHO), American College of Surgeons and InternationalUnion of Risk Management.
Michael Burcham most recently served as president of ParadigmHealth, aspecialty care and disease management provider that integrates care anddisease management services for health plan and employer clients. Prior tojoining ParadigmHealth, Burcham founded and served as president ofTheraphysics, a specialty rehabilitation firm. He began his career inhealthcare with National HealthCorp and Hospital Corporation of America.Burcham is currently professor for the practice of management at the OwenGraduate School of Management at Vanderbilt University.
Kevin Hutchinson is president and CEO of Prematics, developer of thenation's first fully managed electronic medication prescribing solution. Priorto joining Prematics, Hutchinson was the founding president and CEO ofSureScripts, where he led the effort to finance, build and deploy the PharmacyHealth Information Exchange, a national network for electronic prescribing andhealth information exchange.
PharmMD's other advisory board members include Gregg Lehman, Ph.D.,president and CEO of Health Fitness Corporation; Dennis Delaney, executivevice president of human resources and administration for Ingram Industries;and Michael Hogue, Pharm.D., assistant professor of pharmacy practice at theMcWhorter School of Pharmacy at Samford University in Birmingham, Ala.
"Medication-related health issues remain a critical problem both forinsurers and for countless individuals across the country," said BoBartholomew, co-founder and CEO of PharmMD. "Our advisory board has offeredinvaluable counsel as we have fine-tuned our services and implemented ourmarket strategy to address these issues. We are excited to welcome Martin,Michael and Kevin at such a strategic time in our company's development."
PharmMD is an MTM provider based in Brentwood, Tenn., that works withemployers and payers to help ensure that beneficiaries are receiving the mostappropriate medications. Founded in 2006, PharmMD improves coordination andcommunication among physicians, pharmacists, payers and patients by analyzingpharmacy and medical claims information and clinical decision making. BecausePharmMD focuses exclusively on MTM, the company is able to analyze bothaggregate and patient-specific data to identify trends and conflicts topositively impact patient health and contain costs. More information atwww.pharmmd.com.
You May Also Like